u/nils_tulloch

What was the comparator?

Push back: an open-label extension tells you about the people who stayed. That is a different question.

What was the discontinuation rate?

Small fix — that was the cardiovascular outcomes trial, so weight was a secondary endpoint and the population was different.

Four observations is not a distribution. The lane tables here only became predictive once individual routes had a dozen or more reports behind them.

Yes. The habits have to outlive the dose or the maintenance phase is just a countdown.

Open-label extensions lose their randomisation. Anybody still enrolled at week 104 is a selected group and the numbers describe that group.

Agreed on rigid packaging. It costs the shipper almost nothing and it predicts a lot about the rest of the operation.

Not convinced.

Agreed — and appetite is the leading indicator. The scale is the lagging one.

Agreed. Lowest effective dose is the actual maintenance question and it gets almost no airtime next to the escalation threads.

What is the plan if the drift continues for another month?

Careful — anything touching pregnancy is not a board question in any form.

This is the practical fix for half the confusing weeks on this board — annotate the cycle.

Same lane, four orders, 14 to 7 days, all four within a couple of days of the quote. That consistency is the actual finding.

STEP is semaglutide obesity, SURMOUNT is tirzepatide obesity, they are not interchangeable

Do you have the publication or the press release?

This is the practical fix for half the confusing weeks on this board — annotate the cycle.

Disagreeing with this line: the absorption question has a product-specific answer and a pharmacist has it.

Same lane, four orders, 8 to 16 days, all four within a couple of days of the quote. That consistency is the actual finding.

Right — appetite returns before the scale moves, which is the early signal people miss.

Total transit decomposes into first mile, international leg, clearance and last mile. Only the first two are meaningfully under the shipper’s control and most reported variance sits in the last two.

Body weight varies by a couple of kilos over days in stable people through fluid, glycogen and gut content. A range is not a trend.

Agreed on comparators. "Superior" means nothing until you know superior to what and at what dose.

Chased the last three kilos with a dose increase and got a fortnight of reflux and no change in the number.

Packaging is assessable on arrival with no equipment: rigid outer, no movement inside, the cold element sized to the transit rather than to the box.

The habits from the losing phase are what carry it now. That is not inspirational, it is just what happened.